Ladophar updates charter, capital structure, and governance

Lam Dong Pharmaceutical Joint Stock Company (Ladophar) officially announced its 19th amended charter, effective August 22, 2025, following approval by the general meeting of shareholders on April 24, 2025. This latest amendment primarily updates the company's charter capital and incorporates changes to corporate governance.

The company's revised charter capital is set at VND 133,381,670,000, divided into 13,338,167 shares, with a par value of VND 10,000 per share. The charter also details the company's legal representatives, specifying that the chairman of the board of directors and the general director jointly hold this responsibility, with defined authorities. The board of directors will consist of five members, with terms not exceeding five years, and at least one-third of the board members must be independent and non-executive.

Key operational updates include detailed provisions for shareholder meetings, voting mechanisms, and conditions for passing resolutions. The charter also formalizes the structure and responsibilities of the audit committee, which will comprise at least two members, with the chairman being an independent board member. These revisions aim to enhance transparency and align the company’s operations with current legal requirements for public companies.